Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.10.0.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Concentration Risk [Line Items]        
Revenues $ 95,291 $ 69,030 $ 271,580 $ 185,651
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 74,149 51,844 212,773 142,123
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 21,142 $ 17,186 $ 58,807 $ 43,528